Breaks Categories: News

MondayApr 17, 2017 11:38 am

NetworkNewsBreaks – Westport Fuel Systems (NASDAQ: WPRT) Signs Definitive Agreement to Sell its APU Assets for $70M; Shares Rally

Westport Fuel Systems (NASDAQ: WPRT) shares jumped 16% this morning after the company said it has entered into a definitive agreement to sell the assets of its Auxiliary Power Unit (APU) business for $70 million. The sale is consistent with the company’s strategy to streamline its business and focus on alternative fuel solutions for the transportation and automotive industries. The transaction is expected to close within a few weeks. "After a careful assessment of the APU product line and its fit with the other Westport Fuel Systems businesses, we decided it made the most sense for our shareholders to pursue…

Continue Reading

MondayApr 17, 2017 9:44 am

NetworkNewsBreaks – CytoDyn’s (CYDY) PRO 140 Not Granted Orphan Drug Designation Due to Broad HIV Treatment Potential

Biotechnology company CytoDyn Inc. (OTCQB: CYDY) this morning announced that its application for Orphan Drug Designation for PRO 140 was not granted by the Office of Orphan Products Development of the U.S. Food and Drug Administration. Per the update, the company’s clinical stage monoclonal antibody was deemed to have potential to treat more than just the subset of multi-drug resistant HIV patients for which the designation was requested. CytoDyn is currently conducting multiple Phase 2b/3 trials of PRO 140, including one in combination with other antiretroviral agents in the patient population outlined in the company’s Orphan Drug Designation application, as…

Continue Reading

WednesdayApr 12, 2017 12:23 pm

NetworkNewsBreaks – SeeThruEquity Updates Coverage on Medical Transcription Billing, Corp. (NASDAQ: MTBC)

SeeThruEquity recently issued an update on Medical Transcription Billing (NASDAQ: MTBC). The news follows the company’s report of financial results for the quarter and year ended December 31, 2016. MTBC reported full year revenues in 2016 of $24.5 million, a 6% increase over $23.1 million in 2015. The company also reported 65% year-over-year growth in the fourth quarter of 2016 with revenues of $8.8 million. The analyst noted this in the report and attributes the growth primarily to the company’s recent acquisition of MediGain LLC and its subsidiary, Millennium Practice Management, LLC. According to company management, the acquisition of MediGain…

Continue Reading

WednesdayApr 12, 2017 10:39 am

NetworkNewsBreaks – Grey Cloak Tech, Inc. (GRCK) Completes Acquisition of ShareRails

Grey Cloak Tech, Inc. (OTC: GRCK) this morning announced the completion of its acquisition of ShareRails, a provider of online-to-offline (O2O) e-commerce services that is currently valued at more than $6.4 million by Excel Management Systems. “This is a great opportunity for Grey Cloak Tech,” Fred Covely, CEO of Grey Cloak Tech, stated in the news release. “Our entire management team spent a week in Hong Kong last month with the ShareRails development team. We met with the platform's existing clients, as well as developed new relationships, and recognize that the online-to-offline business opportunities are substantial in the southeast region…

Continue Reading

TuesdayApr 11, 2017 1:16 pm

NetworkNewsBreaks – Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) Meets Phase 1 Portion of Intratumoral IMO-2125 Combination Trial, Begins Enrolling Phase 2 Trial

Idera Pharmaceuticals (NASDAQ: IDRA) this morning announced the successful completion of the phase 1 portion of the ongoing phase 1/2 clinical trial of intratumoral IMO-2125 for the treatment of anti-PD-1 refractory metastatic melanoma. Enrollment has commenced for the phase 2 portion of the trial, and Idera expects to have overall response rate (ORR) data available in the first quarter of 2018. “There is a very clear unmet medical need for those patients for whom current checkpoint inhibitor therapies are not providing adequate solutions. We are incredibly focused on advancing this program as rapidly as possible for these patients, and we…

Continue Reading

TuesdayApr 11, 2017 10:05 am

NetworkNewsBreaks – Bollente Companies’ (BOLC) trutankless® Line Selected for Multiple Projects by Leading Senior Living Management Company

Bollente Companies, Inc. (OTCQB: BOLC) this morning announced that its innovative trutankless® line of smart water heaters has been selected for both a retrofit project and new construction of townhomes at Friendship Village, a retirement community located in Tempe, Arizona. The property is owned by Life Care Services Corporation, a leading senior living management and development company. “With its small footprint, energy savings and inherent longevity, trutankless is an ideal solution for the senior living industry which is expected to continue to outpace the overall economy,” Michael Stebbins of Bollente Companies stated in this morning’s news release. “Besides all the…

Continue Reading

TuesdayApr 11, 2017 9:40 am

NetworkNewsBreaks – CytoDyn Inc. (CYDY) Adds Dr. Scott A. Kelly to Board of Directors

Biotechnology company CytoDyn Inc. (OTCQB: CYDY) this morning announced the addition of Scott A. Kelly, M.D., FAAPMR, to its board of directors, effective April 10, 2017. With this appointment, the company’s board of directors now includes eight members. “Scott is passionate about target-specific treatments and personalized medicine that improve the lives of patients,” Denis R. Burger, Ph.D., vice chairman and chief science officer of CytoDyn, stated in the news release. “He has been a supporter and significant investor in CytoDyn, and we look forward to his contributions to our Company as a member of our Board.” Kelly brings considerable industry…

Continue Reading

MondayApr 10, 2017 12:13 pm

NetworkNewsBreaks – Cytori (NASDAQ: CYTX) Shares Surge on FDA Approval for RELIEF Trial Linked to BARDA Contract

Shares of Cytori Therapeutics (NASDAQ: CYTX) are up 34% in morning trade after the company said that the U.S. Food and Drug Administration (FDA) has approved an Investigational Device Exemption (IDE) for a pilot clinical trial to evaluate Cytori Cell Therapy™ in patients with thermal burn injury. The RELIEF trial continues the company’s ongoing research and development work under its contract with the Biomedical Advanced Research and Development Authority (BARDA), a division of the U.S. Department of Health and Human Services. The trial will assess safety and feasibility of intravenous delivery of Cytori Cell Therapy™ as an adjunct to usual…

Continue Reading

MondayApr 10, 2017 11:22 am

NetworkNewsBreaks – ProBility Media Corp. (PBYA) Adds Crane Industry Veteran Billy Smith to Vocational Advisory Board

Education technology company ProBility Media Corp. (OTCQB: PBYA) today announced the appointment of William “Billy” Smith, Jr. to its newly-created vocational advisory board. Smith is a crane and rigging industry veteran who currently serves as a commissioner for the National Commission for the Certification of Crane Operators. He also holds the position of Executive Vice President of NBIS Claims and Risk Management with NationsBuilders Insurance Services, which provides crane and rigging insurance services. “We are delighted and incredibly fortunate to have Billy, with his incredible resume, on our team,” Evan Levine and Noah Davis, executive management at ProBility, stated in…

Continue Reading

MondayApr 10, 2017 10:01 am

NetworkNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Submits International Patent Applications for IGC-501

India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced that it has filed patent applications for IGC-501 in Canada, Israel and Europe in support of its ongoing cannabis-based combination therapy development initiatives. “We continue to strengthen our IP position in cannabis-based combination therapies and have progressed to include global patent filings,” Ram Mukunda, CEO of IGC, stated in the news release. “IGC is committed to addressing high potential international markets as a first mover in this emerging segment of cannabis-based combination therapy pharmaceuticals.” IGC-501 is being developed…

Continue Reading